Occurrence of emerging brominated flame retardants and organophosphate esters in marine wildlife from the Norwegian Arctic

To understand the exposure and potential sources of emerging brominated flame retardants (EBFR) and organophosphate esters (OPEs) in marine wildlife from the Norwegian Arctic, we investigated concentrations of EBFRs in 157 tissue samples from nine species of marine vertebrates and OPEs in 34 samples...

Full description

Bibliographic Details
Published in:Environmental Pollution
Main Authors: Lippold, Anna, Harju, Mikael, Aars, Jon, Blévin, Pierre, Bytingsvik, Jenny, Gabrielsen, Geir W., Kovacs, Kit M., Lyche, Jan Ludwig, Lydersen, Christian, Rikardsen, Audun H., Routti, Heli Anna Irmeli
Format: Article in Journal/Newspaper
Language:English
Published: Elsevier 2022
Subjects:
Online Access:https://hdl.handle.net/10037/27215
https://doi.org/10.1016/j.envpol.2022.120395
Description
Summary:To understand the exposure and potential sources of emerging brominated flame retardants (EBFR) and organophosphate esters (OPEs) in marine wildlife from the Norwegian Arctic, we investigated concentrations of EBFRs in 157 tissue samples from nine species of marine vertebrates and OPEs in 34 samples from three whale species. The samples, collected from a wide range of species with contrasting areal use and diets, included blubber of blue whales, fin whales, humpback whales, white whales, killer whales, walruses and ringed seals and adipose tissue and plasma from polar bears, as well as adipose tissue from glaucous gulls. Tris(2-ethylhexyl) phosphate (TEHP) and tris(2-chloroisopropyl) phosphate (TCIPP) ranged from <0.61 to 164 and < 0.8–41 ng/g lipid weight, respectively, in blue whales and fin whales. All other EBRFs and OPEs were below the detection limit or detected only at low concentration. In addition to the baseline information on the occurrence of EBFRs and OPEs in marine wildlife from the Arctic, we provide an in-depth discussion regarding potential sources of the detected compounds. This information is important for future monitoring and management of EBFRs and OPEs.